EM-T3Pharmacoepidemiology and Drug Safety2025-09-01第 34 卷第 9 期，e70206-e70206开放获取
Effectiveness of Additional Risk Minimization Measures Related to Interstitial Lung Disease/Pneumonitis With Trastuzumab Deruxtecan Treatment of Breast Cancer in European Countries: Results and Learnings From a Post‐Authorization Safety Survey Among Physicians
